NextCell Pharma AB ("NextCell" or the "Company") today announces that six-year follow-up data indicate that a single infusion of ProTrans provides a long-lasting and clinically relevant preservation o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback